Canaccord raised the firm’s price target on HealthStream (HSTM) to $24 from $21 and keeps a Hold rating on the shares. The firm updated its model following Q1 results and where the overhang of churn in legacy Credentialing and Scheduling products has been a consistent headwind to revenue growth for several quarters.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSTM: